NEW YORK–(BUSINESS WIRE)–#FanDuelBestBall–Today, FanDuel announced the expansion of its industry-leading fantasy sports products with the launch of Best Ball and Daily Snake Drafts ahead of the football season. Best Ball contests are the simplest way to play fantasy football, bringing the popular
The BeachWalk at Sea Bright – nestled between the Navesink River and the Atlantic Ocean in Sea Bright, NJ – will be rebranded to a one-of-a-kind independent hotel in partnership with Life Hospitality, marking the tech-enabled operator’s entrance to the New Jersey
Additional Proceeds From Private Placement Transaction Will Provide The Company With Opportunistic Capital FORT LEE, N.J.–(BUSINESS WIRE)–CRB Group, Inc., the parent company of Cross River Bank, today announced the closing of its $106 million private placement of subordinated notes (the “Notes”). “We
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has downgraded the Financial Strength Rating to B+ (Good) from B++ (Good) and the Long-Term Issuer Credit Rating to “bbb-” from “bbb” of Armed Forces Insurance Exchange (AFIE) (Leavenworth, KS). The outlooks of these Credit Ratings (ratings) has
Masks Will Go to Communities in Need in the United States After Fans Dance to Hit Song “Skechers” by DripReport on TikTok—A Track Shared More Than a Billion Times to Date MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Skechers got the world dancing for a cause
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” of American International Group, Inc. (AIG) (headquartered in New York, NY) [NYSE: AIG]. AM Best also has affirmed the Financial Strength Rating (FSR) of A (Excellent) and
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” of Fidelity Life Association, A Legal Reserve Life Insurance Company (FLA) (Chicago, IL). The outlook of these Credit Ratings (ratings) is
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that preclinical research on dantrolene sodium was published today in the peer-reviewed Journal of Alzheimer’s Disease.1 The article reported results from an academic-based study that demonstrated dantrolene sodium
KEYTRUDA Is First Anti-PD-1 Therapy in Combination With Chemotherapy to Show Superior Survival Benefit as First-Line Treatment for Patients With Esophageal Cancer Regardless of Histology Results of Phase 3 KEYNOTE-590 Trial to be Submitted to Global Regulatory Authorities KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck